Literature DB >> 20708156

Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase.

Hiroyuki Inuzuka1, Alan Tseng, Daming Gao, Bo Zhai, Qing Zhang, Shavali Shaik, Lixin Wan, Xiaolu L Ang, Caroline Mock, Haoqiang Yin, Jayne M Stommel, Steven Gygi, Galit Lahav, John Asara, Zhi-Xiong Jim Xiao, William G Kaelin, J Wade Harper, Wenyi Wei.   

Abstract

Mdm2 is the major negative regulator of the p53 pathway. Here, we report that Mdm2 is rapidly degraded after DNA damage and that phosphorylation of Mdm2 by casein kinase I (CKI) at multiple sites triggers its interaction with, and subsequent ubiquitination and destruction, by SCF(beta-TRCP). Inactivation of either beta-TRCP or CKI results in accumulation of Mdm2 and decreased p53 activity, and resistance to apoptosis induced by DNA damaging agents. Moreover, SCF(beta-TRCP)-dependent Mdm2 turnover also contributes to the control of repeated p53 pulses in response to persistent DNA damage. Our results provide insight into the signaling pathways controlling Mdm2 destruction and further suggest that compromised regulation of Mdm2 results in attenuated p53 activity, thereby facilitating tumor progression. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20708156      PMCID: PMC2923652          DOI: 10.1016/j.ccr.2010.06.015

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  58 in total

Review 1.  The DNA damage response: ten years after.

Authors:  J Wade Harper; Stephen J Elledge
Journal:  Mol Cell       Date:  2007-12-14       Impact factor: 17.970

2.  A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells.

Authors:  Wenwei Hu; Zhaohui Feng; Lan Ma; John Wagner; J Jeremy Rice; Gustavo Stolovitzky; Arnold J Levine
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

3.  Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo.

Authors:  Georgios Giamas; Heidrun Hirner; Levani Shoshiashvili; Arnhild Grothey; Susanne Gessert; Michael Kühl; Doris Henne-Bruns; Constantinos E Vorgias; Uwe Knippschild
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

4.  PML enhances the regulation of p53 by CK1 in response to DNA damage.

Authors:  O Alsheich-Bartok; S Haupt; I Alkalay-Snir; S Saito; E Appella; Y Haupt
Journal:  Oncogene       Date:  2008-02-04       Impact factor: 9.867

5.  Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage.

Authors:  Eric Batchelor; Caroline S Mock; Irun Bhan; Alexander Loewer; Galit Lahav
Journal:  Mol Cell       Date:  2008-05-09       Impact factor: 17.970

6.  Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization.

Authors:  Qingqing Ding; Xianghuo He; Jung-Mao Hsu; Weiya Xia; Chun-Te Chen; Long-Yuan Li; Dung-Fang Lee; Jaw-Ching Liu; Qing Zhong; Xiaodong Wang; Mien-Chie Hung
Journal:  Mol Cell Biol       Date:  2007-03-26       Impact factor: 4.272

Review 7.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.

Authors:  Franck Toledo; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

Review 8.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

9.  Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation.

Authors:  Koji Itahana; Hua Mao; Aiwen Jin; Yoko Itahana; Hilary V Clegg; Mikael S Lindström; Krishna P Bhat; Virginia L Godfrey; Gerard I Evan; Yanping Zhang
Journal:  Cancer Cell       Date:  2007-10       Impact factor: 31.743

Review 10.  Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.

Authors:  David Frescas; Michele Pagano
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

View more
  117 in total

Review 1.  Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk.

Authors:  Stian Knappskog; Per E Lønning
Journal:  Transcription       Date:  2011 Sep-Oct

2.  Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancer.

Authors:  Yang Yang; Yunxia Hu; Yuhua Wang; Jun Li; Feng Liu; Leaf Huang
Journal:  Mol Pharm       Date:  2012-06-22       Impact factor: 4.939

3.  SCFFBXO22 targets HDM2 for degradation and modulates breast cancer cell invasion and metastasis.

Authors:  Jin Bai; Kenneth Wu; Meng-Han Cao; Yingying Yang; Yu Pan; Hui Liu; Yizhou He; Yoko Itahana; Lan Huang; Jun-Nian Zheng; Zhen-Qiang Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-28       Impact factor: 11.205

4.  SCFCdc4 enables mating type switching in yeast by cyclin-dependent kinase-mediated elimination of the Ash1 transcriptional repressor.

Authors:  Qingquan Liu; Brett Larsen; Marketa Ricicova; Stephen Orlicky; Hille Tekotte; Xiaojing Tang; Karen Craig; Adam Quiring; Thierry Le Bihan; Carl Hansen; Frank Sicheri; Mike Tyers
Journal:  Mol Cell Biol       Date:  2010-11-22       Impact factor: 4.272

Review 5.  Cyclin D1, cancer progression, and opportunities in cancer treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  J Mol Med (Berl)       Date:  2016-10-02       Impact factor: 4.599

Review 6.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

Review 7.  Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D).

Authors:  Pengfei Xu; Chiara Ianes; Fabian Gärtner; Congxing Liu; Timo Burster; Vasiliy Bakulev; Najma Rachidi; Uwe Knippschild; Joachim Bischof
Journal:  Gene       Date:  2019-07-31       Impact factor: 3.688

8.  Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis.

Authors:  Michael I Carr; Justine E Roderick; Hugh S Gannon; Michelle A Kelliher; Stephen N Jones
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

9.  The anaphase-promoting complex/cyclosome is an E3 ubiquitin ligase for Mdm2.

Authors:  Yizhou He; Laura Tollini; Tae-Hyung Kim; Yoko Itahana; Yanping Zhang
Journal:  Cell Cycle       Date:  2014-05-07       Impact factor: 4.534

10.  CK1δ: a pharmacologically tractable Achilles' heel of Wnt-driven cancers?

Authors:  Jit Kong Cheong; David M Virshup
Journal:  Ann Transl Med       Date:  2016-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.